Evidence map›Paper›PMID 33105608›Full record

ArticleInternational journal of molecular sciences2020

Truncating Variants Contribute to Hearing Loss and Severe Retinopathy in

Akira Inaba, Akiko Maeda, Akiko Yoshida, Kanako Kawai, Yasuhiko Hirami, Yasuo Kurimoto, Shinji Kosugi, Masayo Takahashi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Novel compound heterozygous variants in theFrontiers in cell and developmental biology · 2023
    Article
  7. Inherited Retinal Diseases.International journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Investigating Biomarkers forInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Global spectrum ofFrontiers in aging neuroscience · 2022
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Akira InabaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Akiko MaedaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Akiko YoshidaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Kanako KawaiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Yasuhiko HiramiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Yasuo KurimotoDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
Shinji KosugiDepartment of Medical Ethics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Masayo TakahashiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.
RIKEN Center for Biosystems Dynamics Research · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAge of OnsetAsian PeopleExtracellular Matrix ProteinsFemaleGenetic Association StudiesGenetic VariationHearing LossHumansMaleMiddle AgedRetinal DiseasesRetinitis PigmentosaUsher SyndromesVisual AcuityExtracellular Matrix ProteinsUSH2A protein, humanclinical sequenceinherited retinal degenerationretinitis pigmentosaUSH2AUsher syndrome

Identifiers

PMID33105608
PMCPMC7659936
OpenAlexW3093819542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.